Miyoshi Fukui

644 total citations
32 papers, 527 citations indexed

About

Miyoshi Fukui is a scholar working on Molecular Biology, Spectroscopy and Pharmacology. According to data from OpenAlex, Miyoshi Fukui has authored 32 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Spectroscopy and 7 papers in Pharmacology. Recurrent topics in Miyoshi Fukui's work include Analytical Chemistry and Chromatography (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Metabolism and Genetic Disorders (4 papers). Miyoshi Fukui is often cited by papers focused on Analytical Chemistry and Chromatography (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Metabolism and Genetic Disorders (4 papers). Miyoshi Fukui collaborates with scholars based in Japan and United States. Miyoshi Fukui's co-authors include Fumiyo Kasuya, G Stamatoyannopoulos, Kazuo Igarashi, Kazuei Igarashi, Neal Castagnoli, Etsuko Usuki, Yumiko Yamaoka, Mayumi Nishikawa, Fusako Kawai and Michiaki Tatsuno and has published in prestigious journals such as Journal of Chromatography A, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Miyoshi Fukui

31 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyoshi Fukui Japan 13 202 130 86 73 51 32 527
Jeffrey W. Cox United States 13 158 0.8× 91 0.7× 54 0.6× 69 0.9× 18 0.4× 24 592
C. Giachetti Italy 11 183 0.9× 55 0.4× 74 0.9× 92 1.3× 30 0.6× 37 637
Donald G. Gardiner United Kingdom 13 269 1.3× 41 0.3× 28 0.3× 60 0.8× 28 0.5× 21 735
J Pachecka Poland 15 174 0.9× 37 0.3× 94 1.1× 58 0.8× 28 0.5× 57 556
Roger A. Burges United Kingdom 19 499 2.5× 85 0.7× 37 0.4× 68 0.9× 44 0.9× 27 1.1k
Ping Su China 16 267 1.3× 56 0.4× 118 1.4× 42 0.6× 11 0.2× 33 747
Hideo Yoshizumi Japan 16 213 1.1× 28 0.2× 48 0.6× 81 1.1× 75 1.5× 42 677
Shigeharu Tanayama Japan 15 374 1.9× 42 0.3× 101 1.2× 34 0.5× 26 0.5× 58 730
Stanley R. Howell United States 11 151 0.7× 36 0.3× 118 1.4× 45 0.6× 8 0.2× 20 452
Yoshihiko Shinohara Japan 18 245 1.2× 23 0.2× 85 1.0× 191 2.6× 146 2.9× 72 861

Countries citing papers authored by Miyoshi Fukui

Since Specialization
Citations

This map shows the geographic impact of Miyoshi Fukui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyoshi Fukui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyoshi Fukui more than expected).

Fields of papers citing papers by Miyoshi Fukui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyoshi Fukui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyoshi Fukui. The network helps show where Miyoshi Fukui may publish in the future.

Co-authorship network of co-authors of Miyoshi Fukui

This figure shows the co-authorship network connecting the top 25 collaborators of Miyoshi Fukui. A scholar is included among the top collaborators of Miyoshi Fukui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyoshi Fukui. Miyoshi Fukui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kasuya, Fumiyo, et al.. (2000). Metabolism of an ionic contrast medium and the related agents. Journal of Chromatography B Biomedical Sciences and Applications. 746(1). 25–31.
3.
Kasuya, Fumiyo, et al.. (2000). Difference of the liver and kidney in glycine conjugation of ortho-substituted benzoic acids. Chemico-Biological Interactions. 125(1). 39–50. 21 indexed citations
4.
Kasuya, Fumiyo, et al.. (1999). Characterization of a renal medium chain acyl–CoA synthetase responsible for glycine conjugation in mouse kidney mitochondria. Chemico-Biological Interactions. 118(3). 233–246. 15 indexed citations
5.
Kasuya, Fumiyo, Yumiko Yamaoka, Kazuo Igarashi, & Miyoshi Fukui. (1998). Molecular Specificity of a Medium Chain Acyl-CoA Synthetase for Substrates and Inhibitors. Biochemical Pharmacology. 55(11). 1769–1775. 15 indexed citations
6.
Tsuchihashi, Hitoshi, Mayumi Nishikawa, Kazuo Igarashi, et al.. (1998). Determination of Bromvalerylurea and Its Metabolites in Biological Samples by Frit-Fast Atom Bombardment Liquid Chromatography-Mass Spectrometry. Journal of Analytical Toxicology. 22(7). 591–595. 4 indexed citations
7.
Tokumitsu, Hiroyuki, Yoshinobu Fukumori, Yuko Tsuda, et al.. (1997). Degradation of a Novel Tripeptide, tert-Butoxycarbonyl-Tyr-Leu-Val-CH2Cl, with Inhibitory Effect on Human Leukocyte Elastase in Aqueous Solution and in Biological Fluids.. Chemical and Pharmaceutical Bulletin. 45(11). 1845–1850. 1 indexed citations
8.
Kasuya, Fumiyo, et al.. (1996). Participation of a medium chain acyl-CoA synthetase in glycine conjugation of the benzoic acid derivatives with the electron-donating groups. Biochemical Pharmacology. 51(6). 805–809. 27 indexed citations
9.
Igarashi, Kazuo, et al.. (1996). Effect of a pyridinium metabolite derived from haloperidol on the activities of striatal tyrosine hydroxylase in freely moving rats. Neuroscience Letters. 214(2-3). 183–186. 12 indexed citations
11.
Kasuya, Fumiyo, et al.. (1996). Inhibition of a medium chain acyl-CoA synthetase involved in glycine conjugation by carboxylic acids. Biochemical Pharmacology. 52(10). 1643–1646. 20 indexed citations
12.
Kasuya, Fumiyo, Kazuei Igarashi, Miyoshi Fukui, & Kiyoshi Nokihara. (1996). Purification and characterization of a medium chain acyl-coenzyme A synthetase.. Drug Metabolism and Disposition. 24(8). 879–883. 21 indexed citations
13.
Igarashi, Kazuei, Fumiyo Kasuya, Miyoshi Fukui, Etsuko Usuki, & Neal Castagnoli. (1995). Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP. Life Sciences. 57(26). 2439–2446. 52 indexed citations
14.
Nishikawa, Mayumi, Katsuyoshi Nakajima, Michiaki Tatsuno, et al.. (1994). The analysis of cocaine and its metabolites by liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry (LC/APCI-MS). Forensic Science International. 66(3). 149–158. 32 indexed citations
15.
Kasuya, Fumiyo, Kazuo Igarashi, Miyoshi Fukui, et al.. (1992). Liquid chromatographic/atmospheric pressure chemical ionization mass spectrometric analysis of synthetic elastase inhibitor peptide. Journal of Mass Spectrometry. 21(10). 500–504. 2 indexed citations
16.
Kasuya, Fumiyo, Kazuei Igarashi, & Miyoshi Fukui. (1991). Metabolism of chlorpheniramine in rat and human by use of stable isotopes. Xenobiotica. 21(1). 97–109. 6 indexed citations
17.
Igarashi, Kazuo, Fumiyo Kasuya, & Miyoshi Fukui. (1989). Metabolism of dibucaine. II. Disposition and metabolism of dibucaine in rats.. Journal of Pharmacobio-Dynamics. 12(9). 523–529. 3 indexed citations
18.
Igarashi, Kazuo, et al.. (1987). Determination of dibucaine in biological samples by gas chromatography with a nitrogen-phosphorus detector. Journal of Chromatography B Biomedical Sciences and Applications. 415(2). 407–412. 9 indexed citations
19.
Igarashi, Kazuo, Fumiyo Kasuya, & Miyoshi Fukui. (1983). Metabolism of dibucaine: Isolation and identification of urinary basic metabolites in the rat, rabbit and man.. Journal of Pharmacobio-Dynamics. 6(8). 538–550. 4 indexed citations
20.
Fukui, Miyoshi, et al.. (1972). Liver alcohol dehydrogenase in a Japanese population.. PubMed. 26(1). 46–51. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026